Dr. Paul Pirundini, MD

Thoracic Surgery  ·  
Male  ·  
Age 53
(1)
Insurances Accepted  ·  Save
Dr. Paul Pirundini, MD
Dr. Paul Pirundini, MD is a thoracic surgery specialist in Boston, MA and has been practicing for 19 years. He graduated from New York Med Coll in 1991 and specializes in thoracic surgery.

Risks associated with the TAVR procedure include death, stroke and major bleeding

Important Risk Information for Patients

Indications:

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

Contraindications (Who should not use):

The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

  • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
  • Have an active infection in the heart or elsewhere.

Warnings:

  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
  • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

Precautions:

The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Safety, performance, and durability of the SAPIEN 3 valve has not been established for placement inside a previously implanted transcatheter valve.

The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

  • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure.
  • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.

Potential risks associated with the procedure include:

  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.

Additional potential risks specifically associated with the use of the heart valve include:

  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.

CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-2507 v1.0

Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com

75 Francis St

Boston, MA 02115

Contact Information

(857) 307-4000

Dr. Paul Pirundini, MD

Dr. Paul Pirundini, MD

Accepted insurance

  • Aetna
  • Blue Cross Blue Shield
  • Blue Cross Blue Shield of Louisiana
  • Blue Cross Blue Shield of Massachusetts
  • Cigna
  • Harvard Pilgrim Health Care
  • MultiPlan
  • Tufts Health Plan

*Please verify this information when scheduling an appointment.

Background Check

No malpractice claims found for Massachusetts
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Pirundini's experience treating your condition or procedure

Dr. Pirundini's Top Procedures and Conditions

Treatment Frequency
Chest CT (incl. Heart and Lungs)
high
high

Treatment Frequency

Dr. Pirundini performs Chest CT (incl. Heart and Lungs) more than 89% of his peers

Dr. Pirundini performs this procedure more than 89% of his peers

Lung Surgery
high
high

Treatment Frequency

Dr. Pirundini performs Lung Surgery more than 85% of his peers

Dr. Pirundini performs this procedure more than 85% of his peers

Coronary Artery Bypass Graft (CABG) Surgery
high
high

Treatment Frequency

Dr. Pirundini performs Coronary Artery Bypass Graft (CABG) Surgery more than 85% of his peers

Dr. Pirundini performs this procedure more than 85% of his peers

Rating Includes other areas of care:

  • Multi-Arterial Coronary Artery Bypass Graft (CABG) Surgery
  • Off-Pump Coronary Artery Bypass Graft (CABG) Surgery

Dr. Pirundini's conditions and procedures:

Ablation for Treatment of Cardiac Arrhythmias
Aneurysm
Aneurysm of Heart
Angina and Acute Coronary Syndrome
Aortic Aneurysm
Aortic Dissection
Aortic Ectasia
Aortic Repair, Open or Repair of Arterial Aneurysm, Open
Aortic Stenosis
Aortic Valve Disease
Aortic Valve Regurgitation
Aortic Valve Surgery
Arrhythmias
Atrial Fibrillation
Atrial Flutter
Benign Tumor
Cancer
Cardiac Catheterization (incl. Coronary Angiography)
Cardiac Electrophysiology
Cardiomegaly
Cardiomyopathy
Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
Carotid Artery Disease
Carotid Endarterectomy (CEA) or Excision of Infected Graft
Chest CT (incl. Heart and Lungs)
Congenital Heart Defects
Congenital Heart Disease
Coronary Artery Bypass Graft (CABG) Surgery
Coronary Artery Disease (CAD)
Endocarditis
Esophageal Diseases
Esophageal Surgery
Head and Neck Surgery
Heart Defect Repair
Heart Disease
Heart Surgery
Incision and Removal of Foreign Object
Lung Cancer
Lung Surgery
Mitral Valve Disease
Mitral Valve Regurgitation
Mitral Valve Stenosis
Mitral Valve Surgery
Pericardial Disease
Peripheral Arterial Aneurysm
Peripheral Arterial Aneurysm and Dissection
Peripheral Artery Catheterization
Port Placements or Replacements
Pulmonary Disease
Pulmonary Embolism
Thoracentesis
Thrombosis
Tracheal Surgery
Valve Repair or Replacement (Aortic, Mitral, Tricuspid, and Pulmonary)
Vascular Disease
Vascular Surgical Procedure
Video-Assisted Thoracoscopic Surgery (VATS) or Thoracotomy

About Me

Biography

Dr. Paul Pirundini, MD is a thoracic surgery specialist in Boston, MA and has been practicing for 19 years. He graduated from New York Med Coll in 1991 and specializes in thoracic surgery.

Specialties

  • Thoracic Surgery

Board Certifications

  • General Surgery
  • Thoracic Cardiovascular Surgery

Education

  • 1999
    UMDNJ
    Fellowship Hospital
    1999
  • 1997
    Waterbury Hosp Hlth Ctr
    Residency Hospital
    1997
  • 1992
    U Conn Hlth Ctr
    Internship Hospital
    1992
  • 1991
    New York Med Coll
    Medical School
    1991

Awards

Dr. Pirundini's Reviews

Likelihood to recommend Dr. Pirundini

5.0

Based on 1 reviews

5 Stars
100%
(1)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Pirundini?
(Select your rating)
Average Wait Time
  • Under 10 minutes
Dr. Pirundini's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness

Be the first to leave a comment

How was your experience with Dr. Pirundini?

Locations

Insurance accepted

Accepted insurance can change. Please double-check when making an appointment.

Aetna
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Blue Cross Blue Shield of Louisiana
BlueConnect HMO
Blue Cross Blue Shield of Massachusetts
Preferred Blue PPO
Cigna
Cigna HMO
Cigna PPO
LocalPlus
Open Access Plus
Harvard Pilgrim Health Care
Harvard Pilgrim Health Care PPO
MultiPlan
MultiPlan PPO
PHCS Network PPO
Tufts Health Plan
Tufts PPO

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Pirundini treats patients.

Learn more